Medovex Corp. is a development-stage company. The Company focuses on obtaining, developing and commercializing various intellectual property rights, such as patents and patent applications in the medical technology area, with focus on the development of medical devices. The Company holds rights relating to the use, development and commercialization of the DenerveX Device (DenerveX). Its DenerveX is used in the treatment of conditions resulting from the degeneration of joints in the spine that cause back pain. It focuses to market the DenerveX as a disposable, single-use kit. Its subsidiary Streamline, Inc., is in the business of designing, developing, manufacturing and marketing 510(k) exempt products for use in the medical field. Its intravenous (IV) Suspension System (ISS) is a solution available for managing cumbersome IV poles with mounted IV infusion pumps or other equipment at the bedside and during intra-hospital transports. The Company has not generated any revenue.
